The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of NEO2734, a novel dual inhibitor of both BET and CBP-P300, in SPOP-mutated prostate cancer.
 
Yuqian Yan
No Relationships to Disclose
 
Dejie Wang
No Relationships to Disclose
 
Jian Ma
No Relationships to Disclose
 
Xiaodong Pang
No Relationships to Disclose
 
Dong Lin
No Relationships to Disclose
 
Francis Giles
Employment - Actuate Therapeutics
Leadership - Epigene Therapeutics
Stock and Other Ownership Interests - Epigene Therapeutics
Consulting or Advisory Role - Epigene Therapeutics
Expert Testimony - Novartis Canada Pharmaceuticals Inc
 
Yuzhuo Wang
No Relationships to Disclose
 
Haojie Huang
No Relationships to Disclose